Combination therapy of Eicosapentaenoic acid and pitavastatin for Regression of coronary plaque evaluated by integrated backscatter intravascular ultrasonography; CHERRY study.

Trial Profile

Combination therapy of Eicosapentaenoic acid and pitavastatin for Regression of coronary plaque evaluated by integrated backscatter intravascular ultrasonography; CHERRY study.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Nov 2015

At a glance

  • Drugs Eicosapentaenoic acid (Primary) ; Pitavastatin (Primary)
  • Indications Acute coronary syndromes; Angina pectoris; Atherosclerosis; Hyperlipidaemia
  • Focus Pharmacodynamics; Registrational; Therapeutic Use
  • Acronyms CHERRY
  • Most Recent Events

    • 09 Nov 2015 According to an Amarin Corporation media release, abstract of trial was published in Circulation.
    • 09 Nov 2015 According to an Amarin Corporation media release, results from this trial were presented at the American Heart Association Scientific Sessions.
    • 09 Nov 2015 Results published in the Amarin Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top